Literature DB >> 24866425

Pharmacotherapy: Colchicine for recurrent pericarditis--what's new in CORP-2?

Faisal F Syed1, Bongani M Mayosi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24866425     DOI： 10.1038/nrcardio.2014.71

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Tailoring diagnosis and management of pericardial disease to the epidemiological setting.

Authors:  Faisal F Syed; Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

2.  A randomized trial of colchicine for acute pericarditis.

Authors:  Massimo Imazio; Antonio Brucato; Roberto Cemin; Stefania Ferrua; Stefano Maggiolini; Federico Beqaraj; Daniela Demarie; Davide Forno; Silvia Ferro; Silvia Maestroni; Riccardo Belli; Rita Trinchero; David H Spodick; Yehuda Adler
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

3.  Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.

Authors:  Martina Finetti; Antonella Insalaco; Luca Cantarini; Antonella Meini; Luciana Breda; Maria Alessio; Matteo D'Alessandro; Paolo Picco; Alberto Martini; Marco Gattorno
Journal:  J Pediatr       Date:  2014-03-12       Impact factor: 4.406

4.  Long-term outcomes in difficult-to-treat patients with recurrent pericarditis.

Authors:  Antonio Brucato; Giovanni Brambilla; Antonella Moreo; Antonella Alberti; Carlotta Munforti; Anna Ghirardello; Andrea Doria; Yael Shinar; Avi Livneh; Yehuda Adler; Yehuda Shoenfeld; Francesco Mauri; Giancarlo Palmieri; David H Spodick
Journal:  Am J Cardiol       Date:  2006-06-05       Impact factor: 2.778

5.  Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study.

Authors:  Dali Feng; James Glockner; Kyehun Kim; Matthew Martinez; Imran S Syed; Philip Araoz; Jerome Breen; Raul E Espinosa; Thoralf Sundt; Hartzell V Schaff; Jae K Oh
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

6.  Colchicine for recurrent pericarditis (CORP): a randomized trial.

Authors:  Massimo Imazio; Antonio Brucato; Roberto Cemin; Stefania Ferrua; Riccardo Belli; Silvia Maestroni; Rita Trinchero; David H Spodick; Yehuda Adler
Journal:  Ann Intern Med       Date:  2011-08-28       Impact factor: 25.391

7.  Risk of constrictive pericarditis after acute pericarditis.

Authors:  Massimo Imazio; Antonio Brucato; Silvia Maestroni; Davide Cumetti; Riccardo Belli; Rita Trinchero; Yehuda Adler
Journal:  Circulation       Date:  2011-08-15       Impact factor: 29.690

Review 8.  Prognosis of idiopathic recurrent pericarditis as determined from previously published reports.

Authors:  Massimo Imazio; Antonio Brucato; Yehuda Adler; Giovanni Brambilla; Galit Artom; Enrico Cecchi; Giancarlo Palmieri; Rita Trinchero
Journal:  Am J Cardiol       Date:  2007-07-06       Impact factor: 2.778

9.  Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial.

Authors:  Massimo Imazio; Riccardo Belli; Antonio Brucato; Roberto Cemin; Stefania Ferrua; Federico Beqaraj; Daniela Demarie; Silvia Ferro; Davide Forno; Silvia Maestroni; Davide Cumetti; Ferdinando Varbella; Rita Trinchero; David H Spodick; Yehuda Adler
Journal:  Lancet       Date:  2014-03-30       Impact factor: 79.321

10.  Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion.

Authors:  Mpiko Ntsekhe; Kerryn Matthews; Faisal F Syed; Armin Deffur; Motasim Badri; Patrick J Commerford; Bernard J Gersh; Katalin A Wilkinson; Robert J Wilkinson; Bongani M Mayosi
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240
  10 in total
  1 in total

1.  CORP-2 trial and the role of colchicine in nonidiopathic pericarditis.

Authors:  Lovely Chhabra; Kirandeep Dua; David H Spodick
Journal:  Nat Rev Cardiol       Date:  2014-07-01       Impact factor: 32.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.